AI in Drug Discovery and Clinical Trials: Revolutionizing Treatment Approval
Brief news summary
Over the past year, pharmaceutical companies have increasingly turned to artificial intelligence (AI) to revolutionize drug discovery. AI is considered a game-changing tool that could expedite the approval of treatments for rare diseases, cancer, and antibiotic-resistant infections. However, demonstrating AI's true efficacy will require comprehensive research over the next few years. Currently, some companies employ AI to enhance the efficiency of clinical trials for existing drugs, aiming for faster results. One proposed cutting-edge AI application is the complete simulation of clinical trials to predict clinical and safety outcomes without the need for human participants. This would utilize extensive databases from past trials, real-world patient records, and pharmacokinetic data. Yet, despite its potential, AI is mainly being used to optimize existing processes rather than to pioneer groundbreaking innovations. Morgan Hanger, executive director of the Clinical Trials Transformation Initiative, notes that while AI has significant potential, it is primarily enhancing current practices rather than achieving more ambitious industry goals.Over the past year, drugmakers have highlighted the potential of AI-driven drug discovery, suggesting that it could speed up the approval of treatments for a range of conditions, from rare diseases to cancer and antibiotic-resistant infections. Although it will take years to determine if these claims are valid, other companies are already using machine learning and AI in the design and execution of clinical trials for existing drug candidates, aiming for faster results.
Ideally, AI in clinical trials would mean complete simulation without human participants, predicting outcomes using extensive databases of past trials, real-world patient records, and pharmacokinetic data. However, according to Morgan Hanger, executive director of the Clinical Trials Transformation Initiative, many current applications of AI are focused on optimization rather than the groundbreaking advancements people anticipate.
Watch video about
AI in Drug Discovery and Clinical Trials: Revolutionizing Treatment Approval
Try our premium solution and start getting clients — at no cost to you
